Integra LifeSciences to acquire Surgical Innovation Associates
North America
Adaptive Biotechnologies rolls out clonoSEQ Assay for DLBCL patients
By measuring ctDNA, the clonoSEQ Assay can evaluate the MRD status of DLBCL patients.
HemoSonics receives FDA 510(k) market clearance for Quantra System
Plenty of phish: medical device manufacturers urged to assess cybersecurity risk and readiness
Aspira Women’s Health introduces OvaWatch to assess ovarian cancer risk
Health Canada approves Novocure’s Optune to treat glioblastoma
Boston Scientific to acquire Apollo Endosurgery for $615m
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
